Exact Mass: 315.1470506

Exact Mass Matches: 315.1470506

Found 500 metabolites which its exact mass value is equals to given mass value 315.1470506, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Trispherine

(2S,3S,9S,10S)-9-hydroxy-4-methyl-11,16,18-trioxa-4-azapentacyclo[11.7.0.02,10.03,7.015,19]icosa-1(20),7,13,15(19)-tetraen-12-one

C17H17NO5 (315.1106672)


Hippeastrine is an indole alkaloid isolated from the Amaryllidaceae family and has been shown to exhibit cytotoxic activity. It has a role as an antineoplastic agent and a metabolite. It is an indole alkaloid, a delta-lactone, a secondary alcohol and an organic heteropentacyclic compound. Hippeastrine is a natural product found in Pancratium trianthum, Pancratium canariense, and other organisms with data available.

   

Flusilazole

1-[[Bis(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole, 9ci

C16H15F2N3Si (315.1003254)


CONFIDENCE standard compound; INTERNAL_ID 555; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9550; ORIGINAL_PRECURSOR_SCAN_NO 9549 CONFIDENCE standard compound; INTERNAL_ID 555; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9630; ORIGINAL_PRECURSOR_SCAN_NO 9627 CONFIDENCE standard compound; INTERNAL_ID 555; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9444; ORIGINAL_PRECURSOR_SCAN_NO 9441 CONFIDENCE standard compound; INTERNAL_ID 555; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9499; ORIGINAL_PRECURSOR_SCAN_NO 9497 CONFIDENCE standard compound; INTERNAL_ID 555; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9537; ORIGINAL_PRECURSOR_SCAN_NO 9535 Highly potent broad-spectrum fungicide. Controls broad spectrum of diseases on economically important crops. Flusilazole is found in cereals and cereal products. Flusilazole is found in cereals and cereal products. Highly potent broad-spectrum fungicide. Controls broad spectrum of diseases on economically important crops. CONFIDENCE standard compound; INTERNAL_ID 4011 CONFIDENCE standard compound; INTERNAL_ID 2564 CONFIDENCE standard compound; INTERNAL_ID 8385 D016573 - Agrochemicals D010575 - Pesticides

   

Oxycodone

(1S,5R,13R,17S)-17-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one

C18H21NO4 (315.1470506)


Oxycodone is only found in individuals that have used or taken this drug. It is a semisynthetic derivative of codeine that acts as a narcotic analgesic more potent and addicting than codeine. [PubChem]Oxycodone acts as a weak agonist at mu, kappa, and delta opioid receptors within the central nervous system (CNS). Oxycodone primarily affects mu-type opioid receptors, which are coupled with G-protein receptors and function as modulators, both positive and negative, of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is inhibited. Opioids such as oxycodone also inhibit the release of vasopressin, somatostatin, insulin, and glucagon. Opioids close N-type voltage-operated calcium channels (kappa-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (mu and delta receptor agonist). This results in hyperpolarization and reduced neuronal excitability. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AA - Natural opium alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

(S)-3-Hydroxy-N-methylcoclaurine

4-{[(1S)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}benzene-1,2-diol

C18H21NO4 (315.1470506)


(S)-3-Hydroxy-N-methylcoclaurine is an intermediate in the biosynthesis of alkaloids (KEGG ID C05202). It is the 10th to last step in the synthesis of morphine and is converted from (s)-N-methylcoclaurine via the enzyme tyrosinase [EC:1.14.18.1]. It is then converted to (S)-reticuline. [HMDB] (S)-3-Hydroxy-N-methylcoclaurine is an intermediate in the biosynthesis of alkaloids (KEGG ID C05202). It is the 10th to last step in the synthesis of morphine and is converted from (s)-N-methylcoclaurine via the enzyme tyrosinase [EC:1.14.18.1]. It is then converted to (S)-reticuline.

   

Nororientaline

Nororientaline

C18H21NO4 (315.1470506)


An isoquinoline alkaloid consisting of a tetrahydroisoquinoline core with 4-hydroxy-3-methoxybenzyl, methoxy and hydroxy substituents at positions 1, 6 and 7 respectively; major species at pH 7.3.

   

Norreticuline

(R)-Norreticuline

C18H21NO4 (315.1470506)


   

Belladine

Belladine

C19H25NO3 (315.18343400000003)


A phenethylamine alkaloid that is N-methyl-4-methoxyphenylethylamine carrying an additional N-(3,4-dimethoxybenzyl) substituent.

   

Cephalotaxine

Cephalotaxine

C18H21NO4 (315.1470506)


Cephalotaxlen ((-)-Cephalotaxine) is an alkaloid that can be isolated from Cephalotaxus fortunei, with antileukemic and antiviral activities. Cephalotaxlen has anti-ZIKV (Zika virus) activity[1][2][3]. Cephalotaxlen ((-)-Cephalotaxine) is an alkaloid that can be isolated from Cephalotaxus fortunei, with antileukemic and antiviral activities. Cephalotaxlen has anti-ZIKV (Zika virus) activity[1][2][3].

   

2-Nitroestrone

3-Hydroxy-2-nitroestra-1,3,5(10)-trien-17-one

C18H21NO4 (315.1470506)


   

4-Nitroestrone

3-Hydroxy-4-nitroestra-1,3,5(10)-trien-17-one

C18H21NO4 (315.1470506)


   

Neosaxitoxin

[(4R,10aS,10bS)-2-amino-5,10,10-trihydroxy-6-imino-3H,4H,5H,6H,8H,9H,10H,10bH-pyrrolo[1,2-c]purin-4-yl]methyl carbamate

C10H17N7O5 (315.1291112)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents Neosaxitoxin is produced by Protogonyaulax and found in shellfis D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

   

Clavamycin D

Antibiotic CA 146A

C13H21N3O6 (315.1430286)


   

Alizapride

6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-1,2,3-benzotriazole-5-carboxamide

C16H21N5O2 (315.1695166)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   
   
   

N-Caffeoyldopamine

(E)-N-(3,4-DIHYDROXYPHENETHYL)-3-(3,4-DIHYDROXYPHENYL)ACRYLAMIDE

C17H17NO5 (315.1106672)


   

Codeine N-oxide

14-hydroxy-10-methoxy-4-methyl-12-oxa-4λ⁵-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10,15-tetraen-4-one

C18H21NO4 (315.1470506)


Codeine N-oxide is found in opium poppy. Codeine N-oxide is an alkaloid from Papaver somniferum (opium poppy). Alkaloid from Papaver somniferum (opium poppy). Codeine N-oxide is found in opium poppy.

   

(E)-Piperolein A

(6E)-7-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one

C19H25NO3 (315.18343400000003)


(e)-piperolein a is a member of the class of compounds known as benzodioxoles. Benzodioxoles are organic compounds containing a benzene ring fused to either isomers of dioxole. Dioxole is a five-membered unsaturated ring of two oxygen atoms and three carbon atoms (e)-piperolein a is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). (e)-piperolein a can be found in herbs and spices, which makes (e)-piperolein a a potential biomarker for the consumption of this food product. (E)-Piperolein A is found in herbs and spices. (E)-Piperolein A is a minor constituent of Piper nigrum (pepper

   

(±)-Pandamarine

3-methyl-6-{4-[(2E)-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]butyl}-1,6-diazaspiro[4.5]dec-3-en-2-one

C18H25N3O2 (315.194667)


(±)-Pandamarine is a major alkaloid from leaves of Pandanus amaryllifolius. Major alkaloid from leaves of Pandanus amaryllifolius

   

N-Dihydroferuloyltyramine

3-(4-Hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]propanimidate

C18H21NO4 (315.1470506)


N-Dihydroferuloyltyramine is found in fruits. N-Dihydroferuloyltyramine is an alkaloid from stems of cherimoya (Annona cherimola). Alkaloid from stems of cherimoya (Annona cherimola). N-Dihydroferuloyltyramine is found in fruits.

   

Erythratine

19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,16-tetraen-18-ol

C18H21NO4 (315.1470506)


Erythratine is found in green vegetables. Erythratine is an alkaloid from the seeds of Erythrina glauca (gallito

   

(1R*,3R*,3'S*)-1,2,3,4-Tetrahydro-1-(2-thio-3-pyrrolidinyl)-beta-carboline-3-carboxylic acid

1-(5-Sulphanyl-3,4-dihydro-2H-pyrrol-4-yl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-carboxylic acid

C16H17N3O2S (315.1041422)


(1R*,3S*,3R*)-1,2,3,4-Tetrahydro-1-(2-thio-3-pyrrolidinyl)-beta-carboline-3-carboxylic acid is found in root vegetables. (1R*,3S*,3R*)-1,2,3,4-Tetrahydro-1-(2-thio-3-pyrrolidinyl)-beta-carboline-3-carboxylic acid is an alkaloid from fermented radish root

   

Citpressine II

1-hydroxy-3,5,6-trimethoxy-10-methyl-9,10-dihydroacridin-9-one

C17H17NO5 (315.1106672)


Citpressine II is found in citrus. Citpressine II is an alkaloid from the root of bark of Citrus depressa (Shekwasha mandarin

   

Mitiglinide

Calcium 2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate dihydrate

C19H25NO3 (315.18343400000003)


Mitiglinide is only found in individuals that have used or taken this drug. It is a drug for the treatment of type 2 diabetes.Mitiglinide is thought to stimulate insulin secretion by binding to and blocking ATP-sensitive K(+) (K(ATP)) channels (Kir6.2/SUR1 complex, KATP channels) in pancreatic beta-cells. Closure of potassium channels causes depolarization which stimulates calcium influx through voltage-gated calcium channels. High intracellular calcium subsequently triggers the exocytosis of insulin granules.

   

Alizapride

6-methoxy-N-{[1-(prop-2-en-1-yl)pyrrolidin-2-yl]methyl}-2H-1,2,3-benzotriazole-5-carboxamide

C16H21N5O2 (315.1695166)


Alizapride is only found in individuals that have used or taken this drug. It is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.The anti-emetic action of Alizapride is due to its antagonist activity at D2 receptors in the chemoreceptor trigger zone (CTZ) in the central nervous system (CNS)—this action prevents nausea and vomiting triggered by most stimuli. Structurally similar to metoclopramide and, therefore, shares similar other atributres related to emesis and prokinetics. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

Rotigotine

6-{propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol

C19H25NOS (315.165676)


Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinsons disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well. Rotigotine was developed by Aderis Pharmaceuticals. In 1998, Aderis licensed worldwide development and commercialization rights for rotigotine to the German pharmaceutical company Schwarz Pharma (today a subsidiary of the Belgian company UCB S.A.). The drug has been approved by the EMEA for use in Europe in 2006 and is today being sold in several European countries. In 2007, the Neupro patch was approved by the Food and Drug Administration (FDA) as the first transdermal treatment of Parkinsons disease in the United States. However, as of 2008, Schwarz Pharma has recalled all Neupro patches in the United States and some in Europe because of problems with the delivery mechanism. Rotigotine has been authorized as a treatment for RLS since August 2008. D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

Saxagliptin

(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile

C18H25N3O2 (315.194667)


Saxagliptin (rINN), previously identified as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. It was developed by Bristol-Myers Squibb. A New Drug Application for saxagliptin in the treatment of type 2 diabetes was submitted to the FDA in June 2008. It was based on a drug development program with 8 randomized trials: 1 phase 2 dose-ranging (2.5 - 100 mg/d) study; 6 phase 3, 24-week controlled trials with additional controlled follow-up from 12 to 42 months, double-blinded throughout; and one 12-week mechanism-of-action trial with a 2-year follow-up period. In June 2008, it was announced that Onglyza would be the trade name under which saxagliptin will be marketed. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

N'-Hydroxysaxitoxin

{10,10-dihydroxy-2,6-diimino-hexahydro-1H-pyrrolo[1,2-c]purin-4-yl}methyl N-hydroxycarbamate

C10H17N7O5 (315.1291112)


N-Hydroxysaxitoxin is isolated from the crab Zosimus aeneus. Isolated from the crab Zosimus aeneus.

   

(6Z)-Oct-6-enedioylcarnitine

3-[(7-carboxyhept-6-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO6 (315.168179)


(6Z)-oct-6-enedioylcarnitine is an acylcarnitine. More specifically, it is an (6Z)-oct-6-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (6Z)-oct-6-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (6Z)-oct-6-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Oct-4-enedioylcarnitine

3-[(7-carboxyhept-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO6 (315.168179)


oct-4-enedioylcarnitine is an acylcarnitine. More specifically, it is an oct-4-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. oct-4-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine oct-4-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Oct-5-enedioylcarnitine

3-[(7-carboxyhept-5-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO6 (315.168179)


oct-5-enedioylcarnitine is an acylcarnitine. More specifically, it is an oct-5-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. oct-5-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine oct-5-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-Oct-2-enedioylcarnitine

3-[(7-carboxyhept-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO6 (315.168179)


(2E)-oct-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-oct-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-oct-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-oct-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2R,3R,6S)-4-Methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-ol

(2R,3R,6S)-4-Methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-ol

C18H21NO4 (315.1470506)


   

3-(3,4-Dihydroxyphenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]prop-2-enamide

3-(3,4-Dihydroxyphenyl)-N-[2-(3,4-dihydroxyphenyl)ethyl]prop-2-enimidate

C17H17NO5 (315.1106672)


   

6-Amino-9-benzyl-2-(2-methoxyethoxy)-9H-purin-8-ol

6-amino-9-benzyl-2-(2-methoxyethoxy)-8,9-dihydro-7H-purin-8-one

C15H17N5O3 (315.1331332)


   

Di-deacetyl adrogolide

15-propyl-14-thia-11-azatetracyclo[8.7.0.0^{2,7}.0^{13,17}]heptadeca-2,4,6,13(17),15-pentaene-4,5-diol

C18H21NO2S (315.12929260000004)


   

Antramycin

3-{8,11-dihydroxy-12-methyl-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl}prop-2-enimidate

C16H17N3O4 (315.1219002)


   

Dihydroethidium

5-ethyl-6-phenyl-5,6-dihydrophenanthridine-3,8-diamine

C21H21N3 (315.17353860000003)


   

N-(5-Fluoro-2-piperidin-1-ylphenyl)pyridine-4-carbothioamide

N-[5-fluoro-2-(piperidin-1-yl)phenyl]pyridine-4-carbothioamide

C17H18FN3S (315.12054000000006)


   

Indicine-N-oxide

7-({[2,3-dihydroxy-2-(propan-2-yl)butanoyl]oxy}methyl)-1-hydroxy-1,2,3,4,5,7a-hexahydropyrrolizin-4-ium-4-olate

C15H25NO6 (315.168179)


   

gibberellin A12-aldehyde

(1R,2S,3S,4R,8S,9S,12R)-2-formyl-4,8-dimethyl-13-methylidenetetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadecane-4-carboxylate

C20H27O3 (315.19600920000005)


Gibberellin a12-aldehyde is a member of the class of compounds known as c20-gibberellins. C20-gibberellins are gibberellins with carboxy groups in positions 7 and 18 and some also in 20, while others have an aldehyde group in the latter position. Gibberellin a12-aldehyde is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Gibberellin a12-aldehyde can be found in a number of food items such as custard apple, yellow bell pepper, giant butterbur, and java plum, which makes gibberellin a12-aldehyde a potential biomarker for the consumption of these food products.

   

Synribo

(1S-(1.ALPHA.,3AS*,14B.BETA.))-1,5,6,8,9,14B-HEXAHYDRO-2-METHOXY-4H-CYCLOPENTA(A)(1,3)DIOXOLO(4,5-H)PYRROLO(2,1-B)(3)BENZAZEPIN-1-OL

C18H21NO4 (315.1470506)


Cephalotaxine is a benzazepine alkaloid isolated from Cephalotaxus harringtonia. It is a benzazepine alkaloid, a benzazepine alkaloid fundamental parent, an organic heteropentacyclic compound, an enol ether, a cyclic acetal, a secondary alcohol and a tertiary amino compound. Omacetaxine is a semisynthetic cephataxine that acts as a protein translation inhibitor and is used to treated chronic myeloid leukemia that is resistant to tyrosine kinase receptor antagonists. Omacetaxine is associated with a low rate of serum enzyme elevation during therapy, but has not been linked to cases of clinically apparent liver injury with jaundice. Cephalotaxine is a natural product found in Cephalotaxus hainanensis, Cephalotaxus harringtonia, and other organisms with data available. Omacetaxine is a protein translation inhibitor and cytotoxic plant alkaloid homoharringtonine isolated from the evergreen tree Cephalotaxus, with potential antineoplastic activity. Although the exact mechanism of action has not been fully elucidated, upon administration, omacetaxine targets and binds to the 80S ribosome in eukaryotic cells and inhibits protein synthesis by interfering with chain elongation. This reduces levels of certain oncoproteins and anti-apoptotic proteins. Semisynthetic derivative of harringtonine that acts as a protein synthesis inhibitor and induces APOPTOSIS in tumor cells. It is used in the treatment of MYELOID LEUKEMIA, CHRONIC. See also: Omacetaxine Mepesuccinate (active moiety of). D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D006248 - Harringtonines C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product A benzazepine alkaloid isolated from Cephalotaxus harringtonia. C1907 - Drug, Natural Product Cephalotaxlen ((-)-Cephalotaxine) is an alkaloid that can be isolated from Cephalotaxus fortunei, with antileukemic and antiviral activities. Cephalotaxlen has anti-ZIKV (Zika virus) activity[1][2][3]. Cephalotaxlen ((-)-Cephalotaxine) is an alkaloid that can be isolated from Cephalotaxus fortunei, with antileukemic and antiviral activities. Cephalotaxlen has anti-ZIKV (Zika virus) activity[1][2][3].

   
   

(+)-3-O-demethyl-3-epimacronine

(+)-3-O-demethyl-3-epimacronine

C17H17NO5 (315.1106672)


   
   
   
   
   

(E)-(4-Hydroxycinnamoyl)-epilupinine

(E)-(4-Hydroxycinnamoyl)-epilupinine

C19H25NO3 (315.18343400000003)


   
   

Bisdehydroneostemonine

Bisdehydroneostemonine

C18H21NO4 (315.1470506)


   

(+)-11alpha-Hydroxyerythravine

(+)-11alpha-Hydroxyerythravine

C18H21NO4 (315.1470506)


   

1-O-Acetylnorpluviine

1-O-Acetyl-9-O-demethylpluviine

C18H21NO4 (315.1470506)


   
   

3,9-(2-Imino-1-methyl-4-imidazolidinone-5-yl)isopropenylpurine-6,8-dione

3,9-(2-Imino-1-methyl-4-imidazolidinone-5-yl)isopropenylpurine-6,8-dione

C13H13N7O3 (315.10798280000006)


   
   
   
   

O-methylbalsamide

(+)-O-methylbalsamide

C18H21NO4 (315.1470506)


   

9,10-Dimethoxy-1-methyllycorenan-7-one #

9,10-Dimethoxy-1-methyllycorenan-7-one #

C18H21NO4 (315.1470506)


   
   
   
   
   

(-)-cis-1,2-Dihydroxy-1,2-dihydromedicosmine

(-)-cis-1,2-Dihydroxy-1,2-dihydromedicosmine

C17H17NO5 (315.1106672)


   
   
   
   

Haiderine

O-Demethylhirsutine

C18H21NO4 (315.1470506)


   
   
   

4-Hydroxy-3-methoxydihydrocinnamic acid

4-Hydroxy-3-methoxydihydrocinnamic acid

C17H17NO5 (315.1106672)


   

N-trans-Caffeoyldopamine

(E)-N-(3,4-DIHYDROXYPHENETHYL)-3-(3,4-DIHYDROXYPHENYL)ACRYLAMIDE

C17H17NO5 (315.1106672)


   

(+)-Dihydroperfamine

(+)-Dihydroperfamine

C18H21NO4 (315.1470506)


   

18,19-Dihydroangustine

18,19-Dihydroangustine

C20H17N3O (315.1371552)


   

(S)-3-Hydroxy-N-methylcoclaurine

(S)-3-Hydroxy-N-methylcoclaurine

C18H21NO4 (315.1470506)


An isoquinoline alkaloid having a tetrahydroisoquinoline core with 3,4-dihydroxybenzyl, methoxy and hydroxy groups at the 1-, 6- and 7-positions respectively; major species at pH 7.3.

   

3-Hydroxy-7-O-methylcoclaurine

3-Hydroxy-7-O-methylcoclaurine

C18H21NO4 (315.1470506)


   

6-O-Methyllaudanosoline

6-O-Methyllaudanosoline

C18H21NO4 (315.1470506)


   

(Z)-(4-Hydroxycinnamoyl)-epilupinine

(Z)-(4-Hydroxycinnamoyl)-epilupinine

C19H25NO3 (315.18343400000003)


   

Lupinyl trans-p-coumarate

(-)-(trans-4-Hydroxycinnamoyl)lupinine

C19H25NO3 (315.18343400000003)


   
   
   
   

Alachlor ESA

Alachlor ESA

C14H21NO5S (315.1140376)


An organosulfonic acid that is 2-oxoethanesulfonic acid substituted by (2,6-diethylphenyl)(methoxymethyl)amino group at position 2. It is a metabolite of alachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 99

   

Acetochlor esa

Acetochlor esa

C14H21NO5S (315.1140376)


An organosulfonic acid that is 2-oxoethanesulfonic acid substituted by an (ethoxymethyl)(2-ethyl-6-methylphenyl)amino group at position 2. CONFIDENCE standard compound; EAWAG_UCHEM_ID 103

   

1-(3,4-Dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)propan-2-amine

1-(3,4-Dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)propan-2-amine

C19H25NO3 (315.18343400000003)


   

BUMETRIZOLE

BUMETRIZOLE

C17H18ClN3O (315.1138328)


C1892 - Chemopreventive Agent > C851 - Sunscreen

   

N1-(2-Cyanoethyl)-N1-(3-pyridylmethyl)-4-methyl-1-benzenesulfonamide

N1-(2-Cyanoethyl)-N1-(3-pyridylmethyl)-4-methyl-1-benzenesulfonamide

C16H17N3O2S (315.1041422)


   
   

3,4,5-trimethoxy-N-(1-phenylethyl)benzamide

3,4,5-trimethoxy-N-(1-phenylethyl)benzamide

C18H21NO4 (315.1470506)


   

1-benzhydryl-3-phenoxyazetidine

1-benzhydryl-3-phenoxyazetidine

C22H21NO (315.1623056)


   
   
   

5-[(E)-3-hydroxybut-1-enyl]-4-[4-[(E)-3-oxobut-1-enyl]anilino]oxolan-2-one

5-[(E)-3-hydroxybut-1-enyl]-4-[4-[(E)-3-oxobut-1-enyl]anilino]oxolan-2-one

C18H21NO4 (315.1470506)


   
   
   

3,14-Dihydroangustine

3,14-Dihydroangustine

C20H17N3O (315.1371552)


   
   

6-[(Acetyloxy)methyl]-5,6-dihydro-7-hydroxy-2,2-dimethyl-2H-pyrano[3,2-c]quinolin-5-one

6-[(Acetyloxy)methyl]-5,6-dihydro-7-hydroxy-2,2-dimethyl-2H-pyrano[3,2-c]quinolin-5-one

C17H17NO5 (315.1106672)


   
   
   
   
   

8,14-Dihydro-norsalutaridin

8,14-Dihydro-norsalutaridin

C18H21NO4 (315.1470506)


   

5-(9H-beta-carbolin-1-yl)-5-hydroxy-5,6-dihydro-[2]pyrindin-7-one|Pauridianthinin|Pauridianthinine

5-(9H-beta-carbolin-1-yl)-5-hydroxy-5,6-dihydro-[2]pyrindin-7-one|Pauridianthinin|Pauridianthinine

C19H13N3O2 (315.1007718)


   
   
   

17-demethylsinomenine|N-demethyl-sinomenine|N-demethylsinomenine

17-demethylsinomenine|N-demethyl-sinomenine|N-demethylsinomenine

C18H21NO4 (315.1470506)


   
   

4-(3-methoxy-4-hydroxyphenyl)-4-<2-(acetylmethylamino)ethyl>cyclohexadienone

4-(3-methoxy-4-hydroxyphenyl)-4-<2-(acetylmethylamino)ethyl>cyclohexadienone

C18H21NO4 (315.1470506)


   

(7Z,10S,12Z,13aS)-7,13-epoxy-2,3,9,10,11,13a-hexahydro-5,6-dimethoxy-1H-cyclodec[ij]isoquinolin-10-ol|stephalonganine A

(7Z,10S,12Z,13aS)-7,13-epoxy-2,3,9,10,11,13a-hexahydro-5,6-dimethoxy-1H-cyclodec[ij]isoquinolin-10-ol|stephalonganine A

C18H21NO4 (315.1470506)


   
   
   

ANTHRAMYCIN

ANTHRAMYCIN

C16H17N3O4 (315.1219002)


A member of the class of pyrrolobenzodiazepines that is (11aS)-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine substituted at positions 2, 5, 8, 9 and 11R by a (1E)-3-amino-3-oxoprop-1-en-1-yl, oxo, methyl, hydroxy and hydroxy groups, respectively. It is a natural product isolated from Streptomyces refuineus subsp. thermotolerans. D000970 - Antineoplastic Agents

   
   

(-)-(trans-4-Hydroxycinnamoyl)lupinine

(-)-(trans-4-Hydroxycinnamoyl)lupinine

C19H25NO3 (315.18343400000003)


   

2-O-acetylchlidanthine

2-O-acetylchlidanthine

C18H21NO4 (315.1470506)


   
   

4-[2-(Acetylmethylamino)ethyl]-4-(4-hydroxy-3-methoxyphenyl)-2,4-cyclohexadien-1-one

4-[2-(Acetylmethylamino)ethyl]-4-(4-hydroxy-3-methoxyphenyl)-2,4-cyclohexadien-1-one

C18H21NO4 (315.1470506)


   

trans-3-isobutyl-4-[4-(3-methyl-3-butenyloxy)phenyl]pyrrolidine-2,5-dione

trans-3-isobutyl-4-[4-(3-methyl-3-butenyloxy)phenyl]pyrrolidine-2,5-dione

C19H25NO3 (315.18343400000003)


   

1-Methoxy-2-hydroxy-schelhammericine

1-Methoxy-2-hydroxy-schelhammericine

C19H25NO3 (315.18343400000003)


   
   

11Beta-hydroxy-saxitoxin|11Beta-OH-STX|M2

11Beta-hydroxy-saxitoxin|11Beta-OH-STX|M2

C10H17N7O5 (315.1291112)


   

2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoic acid (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester|leptanthine

2,3-dihydroxy-2-(1-hydroxyethyl)-3-methylbutanoic acid (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester|leptanthine

C15H25NO6 (315.168179)


   
   

11beta-hydroxyerysodine

11beta-hydroxyerysodine

C18H21NO4 (315.1470506)


   

7,8-dehydro-1-methoxyrutaecarpine

7,8-dehydro-1-methoxyrutaecarpine

C19H13N3O2 (315.1007718)


   

10-Epimartensine A|Martensine A

10-Epimartensine A|Martensine A

C18H25N3O2 (315.194667)


   
   
   
   
   
   
   

(7E)-N-(3,4,5-trihydroxyl)phenylethyl-4-hydroxyl-cinnamamide

(7E)-N-(3,4,5-trihydroxyl)phenylethyl-4-hydroxyl-cinnamamide

C17H17NO5 (315.1106672)


   
   

(R)-3-(2-hydroxy-3-methoxy-3-methylbutyl)-5-(3-methyl-1-oxo-2-butenyl)indole

(R)-3-(2-hydroxy-3-methoxy-3-methylbutyl)-5-(3-methyl-1-oxo-2-butenyl)indole

C19H25NO3 (315.18343400000003)


   

11-O-methylcrinamine

11-O-methylcrinamine

C18H21NO4 (315.1470506)


   
   

Morphinan-6,14-diol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.,6.alpha.)-

Morphinan-6,14-diol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.,6.alpha.)-

C18H21NO4 (315.1470506)


   
   
   

(5,8-dihydro-7-methoxy-6-methyl-5,8-dioxo-1-isoquinolinyl)methyl (2Z)-2-methyl-2-butenoate|Renieron|Renierone

(5,8-dihydro-7-methoxy-6-methyl-5,8-dioxo-1-isoquinolinyl)methyl (2Z)-2-methyl-2-butenoate|Renieron|Renierone

C17H17NO5 (315.1106672)


   

1-[(2E)-1-oxo-7-(3,4-methylenedioxy)phenylheptenyl]piperidine|piperine S

1-[(2E)-1-oxo-7-(3,4-methylenedioxy)phenylheptenyl]piperidine|piperine S

C19H25NO3 (315.18343400000003)


   
   
   
   
   

(-)-indolactam I|(-)-indolactam-Ile|Indolactam I

(-)-indolactam I|(-)-indolactam-Ile|Indolactam I

C18H25N3O2 (315.194667)


   

14-formylrutaecarpine

14-formylrutaecarpine

C19H13N3O2 (315.1007718)


   
   

4-methoxy-1-methyl-3-(2S-acetoxy-3-ene-butyl)-2-quinolone

4-methoxy-1-methyl-3-(2S-acetoxy-3-ene-butyl)-2-quinolone

C18H21NO4 (315.1470506)


   

16-hydroxy-3beta,15-dimethoxy-erythrin-1(6)-en-2-one|Erysotinon|erysotinone

16-hydroxy-3beta,15-dimethoxy-erythrin-1(6)-en-2-one|Erysotinon|erysotinone

C18H21NO4 (315.1470506)


   
   
   
   
   
   
   
   
   
   
   
   

N-Benzoyl-4-hydroxy-3-methoxy-phenylalanine

N-Benzoyl-4-hydroxy-3-methoxy-phenylalanine

C17H17NO5 (315.1106672)


   

NCI60_000712

Butanoic acid,3-dihydroxy-2-(1-methylethyl)- (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl) methyl ester, N-oxide, (1R-(1.alpha.,7(2R*,3S*),7a.beta))-

C15H25NO6 (315.168179)


Indicine N-oxide is a natural product found in Tournefortia argentea with data available. Indicine-N-Oxide is a natural pyrrolizidine alkaloid with antineoplastic properties. Indicine-N-oxide alkylates and crosslinks DNA. (NCI04)

   

Rinderine N-oxide

[(7S,8R)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl (2S)-2-hydroxy-2-[(1R)-1-hydroxyethyl]-3-methylbutanoate

C15H25NO6 (315.168179)


   

Echinatine oxide

Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)- (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl) methyl ester, N-oxide, (1R-(1.alpha.,7(2R*,3S*),7a.b.eta.))-

C15H25NO6 (315.168179)


   

Lycopsamine N-oxide

Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, N-oxide, [1R-[1?,7(2S*,3R*),7a?]]-; Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1-hydroxy-4-oxido-1H-pyrrolizin-7-yl)methyl ester, [1R-[1?,7(2S*,3R*),7a?]]-; Intermedine N-oxide

C15H25NO6 (315.168179)


Lycopsamine N-oxide is a natural product found in Symphytum officinale, Neatostema apulum, and Idea leuconoe with data available.

   

oxycodone

oxycodone

C18H21NO4 (315.1470506)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids N - Nervous system > N02 - Analgesics > N02A - Opioids > N02AA - Natural opium alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; INTERNAL_ID 1602 IPB_RECORD: 1423; CONFIDENCE confident structure

   

Acetochlor-ESA

Acetochlor-ESA

C14H21NO5S (315.1140376)


CONFIDENCE standard compound; INTERNAL_ID 2030

   

Flusilazole

Pesticide6_Flusilazole_C16H15F2N3Si_1-[(Bis(4-fluorophenyl)methylsilyl)methyl]-1H-1,2,4-triazole

C16H15F2N3Si (315.1003254)


D016573 - Agrochemicals D010575 - Pesticides CONFIDENCE standard compound; EAWAG_UCHEM_ID 97

   

Safranin

Safranin

[C20H19N4]+ (315.1609634)


Acquisition and generation of the data is financially supported by the Max-Planck-Society IPB_RECORD: 2561; CONFIDENCE confident structure

   

Safranine

3,7-Diamino-2,8-dimethyl-5-phenylphenazin-5-ium

[C20H19N4]+ (315.1609634)


Acquisition and generation of the data is financially supported in part by CREST/JST.

   

Saxagliptin (BMS-477118,Onglyza)

"Saxagliptin (BMS-477118,Onglyza)"

C18H25N3O2 (315.194667)


   

2,3-Dimethoxy-15-methyl-4b,5,6,9,8a,10-hexahydro-16-oxa-8a-aza-cyclopenta[a]phenanthren-17-one

"NCGC00160299-01!2,3-Dimethoxy-15-methyl-4b,5,6,9,8a,10-hexahydro-16-oxa-8a-aza-cyclopenta[a]phenanthren-17-one"

C18H21NO4 (315.1470506)


   

Quinolinone B_130054

Quinolinone B_130054

C17H17NO5 (315.1106672)


   

Codeine N-Oxide

(3R,4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-3-oxido-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-ol

C18H21NO4 (315.1470506)


   

C17H21N3O3_10b-Hydroxy-3-isobutyl-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

NCGC00380254-01_C17H21N3O3_10b-Hydroxy-3-isobutyl-6,10b,11,11a-tetrahydro-2H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4(3H,5aH)-dione

C17H21N3O3 (315.1582836)


   
   

N-methylcoclaurine N-oxide

N-methylcoclaurine N-oxide

[C18H21NO4]- (315.1470506)


   

Hippeastrine

(2S,3S,9S,10S)-9-hydroxy-4-methyl-11,16,18-trioxa-4-azapentacyclo[11.7.0.02,10.03,7.015,19]icosa-1(20),7,13,15(19)-tetraen-12-one

C17H17NO5 (315.1106672)


Hippeastrine is an indole alkaloid isolated from the Amaryllidaceae family and has been shown to exhibit cytotoxic activity. It has a role as an antineoplastic agent and a metabolite. It is an indole alkaloid, a delta-lactone, a secondary alcohol and an organic heteropentacyclic compound. Hippeastrine is a natural product found in Pancratium trianthum, Pancratium canariense, and other organisms with data available. An indole alkaloid isolated from the Amaryllidaceae family and has been shown to exhibit cytotoxic activity. Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Amaryllidaceae alkaloids

   

Intermedine N-oxide

Intermedine N-oxide

C15H25NO6 (315.168179)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2272

   

Lycopsamine N-oxide

Lycopsamine N-oxide

C15H25NO6 (315.168179)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2294

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Mitiglinide

2-benzyl-4-(octahydro-1H-isoindol-2-yl)-4-oxobutanoic acid

C19H25NO3 (315.18343400000003)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98079 - Meglitinide Antidiabetic Agent A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins D007004 - Hypoglycemic Agents

   

Rotigotine

6-{propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol

C19H25NOS (315.165676)


N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist Rotigotine is a potent dopamine receptor agonist with Ki values of 0.71?nM, 4-15?nM, and 83?nM for the dopamine D3 receptor and D2, D5, D4 receptors and dopamine D1 receptor. Rotigotine a partial agonist of the 5-HT1A receptor, and an antagonist of the α2B-adrenergic receptor. Rotigotine can be used for parkinson's disease (PD) research[1][2][3][4].

   

saxagliptin

(1S,3S,5S)-2-[(2S)-2-amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile

C18H25N3O2 (315.194667)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

citpressine II

1-hydroxy-3,5,6-trimethoxy-10-methyl-9,10-dihydroacridin-9-one

C17H17NO5 (315.1106672)


   

Erythratine

19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0^{1,16}.0^{2,10}.0^{4,8}]icosa-2,4(8),9,16-tetraen-18-ol

C18H21NO4 (315.1470506)


   

(E)-Piperolein A

(6E)-7-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one

C19H25NO3 (315.18343400000003)


   

n-dihydroferuloyltyramine

3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]propanamide

C18H21NO4 (315.1470506)


   
   

Codeigene

14-hydroxy-10-methoxy-4-methyl-12-oxa-4$l^{5}-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-4-one

C18H21NO4 (315.1470506)


   

1-(2-sulfanylidenepyrrolidin-3-yl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-carboxylic acid

(1R*,3R*,3'S*)-1,2,3,4-Tetrahydro-1-(2-thio-3-pyrrolidinyl)-beta-carboline-3-carboxylic acid

C16H17N3O2S (315.1041422)


   

(±)-Pandamarine

3-methyl-6-{4-[(2E)-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]butyl}-1,6-diazaspiro[4.5]dec-3-en-2-one

C18H25N3O2 (315.194667)


   

1,3,5-Triazine,hexahydro-1,3,5-triphenyl-

1,3,5-Triazine,hexahydro-1,3,5-triphenyl-

C21H21N3 (315.17353860000003)


   

3-[[2-(4-ethoxyphenoxy)acetyl]amino]benzoic acid

3-[[2-(4-ethoxyphenoxy)acetyl]amino]benzoic acid

C17H17NO5 (315.1106672)


   

2,6-bis(phenylmethoxy)benzonitrile

2,6-bis(phenylmethoxy)benzonitrile

C21H17NO2 (315.1259222)


   

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid

C17H18FN3O2 (315.138298)


   

TERT-BUTYLN-[2-(TOSYLOXY)ETHYL]CARBAMATE

TERT-BUTYLN-[2-(TOSYLOXY)ETHYL]CARBAMATE

C14H21NO5S (315.1140376)


   

O-[(Benzyloxy)carbonyl]-L-tyrosine

O-[(Benzyloxy)carbonyl]-L-tyrosine

C17H17NO5 (315.1106672)


   

1-BENZYL-2-(2-(1-METHYL-1H-PYRROL-2-YL)ETHYL)-1H-BENZO[D]IMIDAZOLE

1-BENZYL-2-(2-(1-METHYL-1H-PYRROL-2-YL)ETHYL)-1H-BENZO[D]IMIDAZOLE

C21H21N3 (315.17353860000003)


   

2-ethylhexyl dihydrogen phosphate,2-(2-hydroxyethylamino)ethanol

2-ethylhexyl dihydrogen phosphate,2-(2-hydroxyethylamino)ethanol

C12H30NO6P (315.18106500000005)


   

(R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid

(R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282078)


   

1-(3,3-diphenylpropyl)piperidinium chloride

1-(3,3-diphenylpropyl)piperidinium chloride

C20H26ClN (315.1753666000001)


   

2-(2-ISOPROPYLAMINO-THIAZOL-4-YL)-7-METHOXY-QUINOLIN-4-OL

2-(2-ISOPROPYLAMINO-THIAZOL-4-YL)-7-METHOXY-QUINOLIN-4-OL

C16H17N3O2S (315.1041422)


   

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid

[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid

C17H18FN3O2 (315.138298)


   

N-Benzyloxycarbonyl-D-tyrosine

N-Benzyloxycarbonyl-D-tyrosine

C17H17NO5 (315.1106672)


   

Dopamantine

Dopamantinum [INN-Latin]

C19H25NO3 (315.18343400000003)


C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

   

N-BOC-AMINO-(1,4-DIOXA-SPIRO[4.5]DEC-8-YL)-ACETICACID

N-BOC-AMINO-(1,4-DIOXA-SPIRO[4.5]DEC-8-YL)-ACETICACID

C15H25NO6 (315.168179)


   

2-(2,5-dimethoxyphenylcarbamoyl)phenyl acetate

2-(2,5-dimethoxyphenylcarbamoyl)phenyl acetate

C17H17NO5 (315.1106672)


   

DIETHYL 2-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YL)MALONATE

DIETHYL 2-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YL)MALONATE

C15H25NO6 (315.168179)


   

2-amino-3-nitro-4,6-diphenylbenzonitrile

2-amino-3-nitro-4,6-diphenylbenzonitrile

C19H13N3O2 (315.1007718)


   

Boc-L-aspartic acid 4-cyclohexyl ester

Boc-L-aspartic acid 4-cyclohexyl ester

C15H25NO6 (315.168179)


   

diphenyl-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]methanol

diphenyl-[(3S)-1,2,3,4-tetrahydroisoquinolin-3-yl]methanol

C22H21NO (315.1623056)


   

methyl n-butylsulfonyl-l-p-hydroxyphenylalanine

methyl n-butylsulfonyl-l-p-hydroxyphenylalanine

C14H21NO5S (315.1140376)


   

4-Desmethoxy Omeprazole

4-Desmethoxy Omeprazole

C16H17N3O2S (315.1041422)


   

BENZYL 2,4-DIOXO-3,4,5,6,8,9-HEXAHYDRO-1H-PYRIMIDO[4,5-D]AZEPINE-7(2H)-CARBOXYLATE

BENZYL 2,4-DIOXO-3,4,5,6,8,9-HEXAHYDRO-1H-PYRIMIDO[4,5-D]AZEPINE-7(2H)-CARBOXYLATE

C16H17N3O4 (315.1219002)


   

1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester

1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester

C16H17N3O4 (315.1219002)


   

N-(3-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(3-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.13898320000004)


   

N-(2-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(2-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.13898320000004)


   

5,6,7,8-TETRAHYDRO-6-(PHENYLMETHYL)-4H-THIENO[2,3-D]AZEPINE-2-CARBOXYLIC ACID, ETHYL ESTER

5,6,7,8-TETRAHYDRO-6-(PHENYLMETHYL)-4H-THIENO[2,3-D]AZEPINE-2-CARBOXYLIC ACID, ETHYL ESTER

C18H21NO2S (315.12929260000004)


   

5-FLUORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINEHYDROCHLORIDE

5-FLUORO-2,3-DIHYDRO-BENZOFURAN-3-YLAMINEHYDROCHLORIDE

C18H18ClNO2 (315.1025998)


   

4-(DIMETHYLAMINO)BENZALDEHYDE DIPHENYLHYDRAZONE

4-(DIMETHYLAMINO)BENZALDEHYDE DIPHENYLHYDRAZONE

C21H21N3 (315.17353860000003)


   
   

Boc-(S)-3-Amino-3-(1-naphthyl)-propionic acid

Boc-(S)-3-Amino-3-(1-naphthyl)-propionic acid

C18H21NO4 (315.1470506)


   

(R)-N-Boc-1-Naphthylalanine

(R)-N-Boc-1-Naphthylalanine

C18H21NO4 (315.1470506)


   

6-[propyl(2-thiophen-3-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol

6-[propyl(2-thiophen-3-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol

C19H25NOS (315.165676)


   

Boc-(R)-3-Amino-3-(1-naphthyl)-propionic acid

Boc-(R)-3-Amino-3-(1-naphthyl)-propionic acid

C18H21NO4 (315.1470506)


   

2-(BIPHENYL-3-YL)-N-PHENETHYLACETAMIDE

2-(BIPHENYL-3-YL)-N-PHENETHYLACETAMIDE

C22H21NO (315.1623056)


   

METHYL (2R)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-(2,5-DIFLUOROPHENYL)PROPANOATE

METHYL (2R)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-(2,5-DIFLUOROPHENYL)PROPANOATE

C15H19F2NO4 (315.1282078)


   

(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid

(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282078)


   

3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid

3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid

C15H19F2NO4 (315.1282078)


   

3-[Bis(2-thienyl)methylene]octahydro-2H-quinolizine

3-[Bis(2-thienyl)methylene]octahydro-2H-quinolizine

C18H21NS2 (315.1115346)


   

BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID

BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID

C15H19F2NO4 (315.1282078)


   

2-Oxazolidinone,4,5,5-triphenyl-

2-Oxazolidinone,4,5,5-triphenyl-

C21H17NO2 (315.1259222)


   

N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANESULFONAMIDE

N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANESULFONAMIDE

C13H22BNO5S (315.13116720000005)


   
   
   

Benzyl 2-Fluoro-4-Morpholinobenzoate

Benzyl 2-Fluoro-4-Morpholinobenzoate

C18H18FNO3 (315.127065)


   

2-(5-Chloro-2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-2-propanyl )phenol

2-(5-Chloro-2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-2-propanyl )phenol

C17H18ClN3O (315.1138328)


   

3-[(2-chlorophenyl)methyl]-7,7-dimethyl-6,8-dihydro-1H-quinoline-2,5-dione

3-[(2-chlorophenyl)methyl]-7,7-dimethyl-6,8-dihydro-1H-quinoline-2,5-dione

C18H18ClNO2 (315.1025998)


   

TERT-BUTYL 3-(2,2-DIMETHYL-4,6-DIOXO-1,3-DIOXAN-5-YL)-3-OXOPROPYLCARBAMATE

TERT-BUTYL 3-(2,2-DIMETHYL-4,6-DIOXO-1,3-DIOXAN-5-YL)-3-OXOPROPYLCARBAMATE

C14H21NO7 (315.13179560000003)


   

(R)-2-(3-Fluorophenyl)pyrrolidine L-Tartrate

(R)-2-(3-Fluorophenyl)pyrrolidine L-Tartrate

C14H18FNO6 (315.11181)


   

1-Benzhydryl-3-phenoxy-azetidine

1-Benzhydryl-3-phenoxy-azetidine

C22H21NO (315.1623056)


   

Boc-D-Asp(OcHex)-OH

Boc-D-Asp(OcHex)-OH

C15H25NO6 (315.168179)


   

(S)-N-Boc-1-Naphthylalanine

(S)-N-Boc-1-Naphthylalanine

C18H21NO4 (315.1470506)


   

Boc-3-(2-naphthyl)-D-alanine

Boc-3-(2-naphthyl)-D-alanine

C18H21NO4 (315.1470506)


   

Boc-3-(2-Naphthyl)-L-alanine

Boc-3-(2-Naphthyl)-L-alanine

C18H21NO4 (315.1470506)


   

1H-Pyrrolo[2,3-b]pyridine-3-ethanamine, 1-[(3-methylphenyl)sulfonyl]-

1H-Pyrrolo[2,3-b]pyridine-3-ethanamine, 1-[(3-methylphenyl)sulfonyl]-

C16H17N3O2S (315.1041422)


   

tert-butyl 3-(quinoxalin-2-yloxy)pyrrolidine-1-carboxylate

tert-butyl 3-(quinoxalin-2-yloxy)pyrrolidine-1-carboxylate

C17H21N3O3 (315.1582836)


   

(4-Amino-5-benzyl-pyrimidin-2-ylsulfanyl)-acetic acid allyl ester

(4-Amino-5-benzyl-pyrimidin-2-ylsulfanyl)-acetic acid allyl ester

C16H17N3O2S (315.1041422)


   

dibutyl hydrogen phosphate, compound with 2,2-iminodiethanol (1:1)

dibutyl hydrogen phosphate, compound with 2,2-iminodiethanol (1:1)

C12H30NO6P (315.18106500000005)


   

2-(4-benzoylphenyl)-2-(4-fluorophenyl)acetonitrile

2-(4-benzoylphenyl)-2-(4-fluorophenyl)acetonitrile

C21H14FNO (315.1059366)


   

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(3-methoxyphenyl)-1-piperazinyl]-

Methanone, (3,5-dimethyl-4-isoxazolyl)[4-(3-methoxyphenyl)-1-piperazinyl]-

C17H21N3O3 (315.1582836)


   

(Z)-2-Methoxy-5-(3,4,5-Trimethoxystyryl)Aniline

(Z)-2-Methoxy-5-(3,4,5-Trimethoxystyryl)Aniline

C18H21NO4 (315.1470506)


   

TERT-BUTYL 3-OXO-2-PHENYL-2,3,4,5-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE-6(7H)-CARBOXYLATE

TERT-BUTYL 3-OXO-2-PHENYL-2,3,4,5-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE-6(7H)-CARBOXYLATE

C17H21N3O3 (315.1582836)


   

1-benzhydryl-3-phenylazetidin-3-ol

1-benzhydryl-3-phenylazetidin-3-ol

C22H21NO (315.1623056)


   

Methyl 4-Fluoro-3-(Methylsulfonyl)benzoate

Methyl 4-Fluoro-3-(Methylsulfonyl)benzoate

C14H18FNO6 (315.11181)


   

(3-hydroxy-2-phenylquinolin-4-yl)-imidazol-1-ylmethanone

(3-hydroxy-2-phenylquinolin-4-yl)-imidazol-1-ylmethanone

C19H13N3O2 (315.1007718)


   
   

Tolmetin sodium dihydrate

Tolmetin (sodium dihydrate)

C15H18NNaO5 (315.1082618)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   
   

tert-Butyl 4-(2-chloro-5-fluoropyrimidin-4-yl)piperidine-1-carboxylate

tert-Butyl 4-(2-chloro-5-fluoropyrimidin-4-yl)piperidine-1-carboxylate

C14H19ClFN3O2 (315.1149756)


   

TERT-BUTYL 5-(4-METHYLPIPERAZIN-1-YL)-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 5-(4-METHYLPIPERAZIN-1-YL)-1H-INDOLE-1-CARBOXYLATE

C18H25N3O2 (315.194667)


   
   

Moxisylyte hydrochloride

Moxisylyte hydrochloride

C16H26ClNO3 (315.16011160000005)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D008916 - Miotics D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Moxisylyte (hydrochloride) is (alpha 1-blocker) antagonist, it can vasodilates cerebral vessels without reducing blood pressure. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. [1][2]

   

(R)-4,5,5-TRIPHENYLOXAZOLIDIN-2-ONE

(R)-4,5,5-TRIPHENYLOXAZOLIDIN-2-ONE

C21H17NO2 (315.1259222)


   
   

4-Dibenzylamino-2-methylbenzo-aldehyde

4-Dibenzylamino-2-methylbenzo-aldehyde

C22H21NO (315.1623056)


   

Morphinan-6,10-diol,7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5a,6a)-

Morphinan-6,10-diol,7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5a,6a)-

C18H21NO4 (315.1470506)


   

Antramycin

ANTHRAMYCIN

C16H17N3O4 (315.1219002)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

   

Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2-carboxylate

Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2-carboxylate

C17H22BNO4 (315.16418020000003)


   

(S)-3-((tert-butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid

(S)-3-((tert-butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid

C18H21NO4 (315.1470506)


   

(R)-Boc-3-(2-naphthyl)-β-Ala-OH

(R)-Boc-3-(2-naphthyl)-β-Ala-OH

C18H21NO4 (315.1470506)


   

Clobenzepam

2-chloro-5-[2-(dimethylamino)ethyl]-11H-benzo[b][1,4]benzodiazepin-6-one

C17H18ClN3O (315.1138328)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

2-((tert-butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid

2-((tert-butoxycarbonyl)amino)-3-(naphthalen-1-yl)propanoic acid

C18H21NO4 (315.1470506)


   

DIETHYL 1,5-DIMETHYL-3-PHENYL-1H-PYRROLE-2,4-DICARBOXYLATE

DIETHYL 1,5-DIMETHYL-3-PHENYL-1H-PYRROLE-2,4-DICARBOXYLATE

C18H21NO4 (315.1470506)


   

(4R,4aS,7S,7aR,12bS)-9-methoxy-3-methyl-1,2,4,7,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol

(4R,4aS,7S,7aR,12bS)-9-methoxy-3-methyl-1,2,4,7,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7-diol

C18H21NO4 (315.1470506)


   

4-Hydroxy Omeprazole Sulfide

4-Hydroxy Omeprazole Sulfide

C16H17N3O2S (315.1041422)


   

N-(4-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(4-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C19H22ClNO (315.13898320000004)


   

Doxepin hydrochloride

(E)-doxepin hydrochloride

C19H22ClNO (315.13898320000004)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D000890 - Anti-Infective Agents > D000935 - Antifungal Agents Doxepin hydrochloride is an orally active tricyclic antidepressant agent. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2[1][2]. Doxepin inhibits reuptake of serotonin and norepinephrine as a tricyclic antidepressant[3].
. Doxepin has therapeutic effects in atopic dermatitis,chronic urticarial,can improve cognitive processes, protect central nervous system[4].
. Doxepin has also been proposed as a protective factor against oxidative stress[5].
.

   

(S)-3-(1-Boc-2-piperazinylmethyl)indole

(S)-3-(1-Boc-2-piperazinylmethyl)indole

C18H25N3O2 (315.194667)


   

Boc-(S)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid

Boc-(S)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid

C15H19F2NO4 (315.1282078)


   
   

(R,R)-OCTAHYDRO-BENZOIMIDAZOLE-2-THIONE

(R,R)-OCTAHYDRO-BENZOIMIDAZOLE-2-THIONE

C18H21NO4 (315.1470506)


   

Boc-(R,S)-3-amino-3-(2-naphthyl)-proponic acid

Boc-(R,S)-3-amino-3-(2-naphthyl)-proponic acid

C18H21NO4 (315.1470506)


   

4-[(4-methoxybenzylidene)amino]azobenzene

4-[(4-methoxybenzylidene)amino]azobenzene

C20H17N3O (315.1371552)


   

6-chloro-N-cyclopentyl-5-(4-ethylphenyl)-2-methylpyrimidin-4-amine

6-chloro-N-cyclopentyl-5-(4-ethylphenyl)-2-methylpyrimidin-4-amine

C18H22ClN3 (315.15021620000005)


   

N-(3-TriethylamMoniumpropyl)-4-Methylpyridinium dibromide

N-(3-TriethylamMoniumpropyl)-4-Methylpyridinium dibromide

C15H28BrN2+ (315.1435728)


   

1-(9,10-DIHYDROANTHRACEN-9-YL)-3-(DIMETHYLAMINO)PROPAN-1-ONE HYDROCHLORIDE

1-(9,10-DIHYDROANTHRACEN-9-YL)-3-(DIMETHYLAMINO)PROPAN-1-ONE HYDROCHLORIDE

C19H22ClNO (315.13898320000004)


   

(2E)-2-(1,3-BENZOTHIAZOL-2-YL)-3-[4-(DIMETHYLAMINO)PHENYL]ACRYLONITRILE

(2E)-2-(1,3-BENZOTHIAZOL-2-YL)-3-[4-(DIMETHYLAMINO)PHENYL]ACRYLONITRILE

C22H21NO (315.1623056)


   

tert-Butyl [(mesitylsulfonyl)oxy]carbamate

tert-Butyl [(mesitylsulfonyl)oxy]carbamate

C14H21NO5S (315.1140376)


   

Benzenamine,N-[(4-methoxyphenyl)methylene]-4-(2-phenyldiazenyl)-

Benzenamine,N-[(4-methoxyphenyl)methylene]-4-(2-phenyldiazenyl)-

C20H17N3O (315.1371552)


   
   

(1R,3R,5R)-2-[(2R)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile

(1R,3R,5R)-2-[(2R)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile

C18H25N3O2 (315.194667)


   
   
   

Saxagliptin (S,R,S,S)-Isomer

Saxagliptin (S,R,S,S)-Isomer

C18H25N3O2 (315.194667)


   

Saxagliptin (R,S,R,S)-Isomer

Saxagliptin (R,S,R,S)-Isomer

C18H25N3O2 (315.194667)


   

Trofinetide

Trofinetide

C13H21N3O6 (315.1430286)


C78272 - Agent Affecting Nervous System Trofinetide (NNZ-2566), a synthetic analogue of the endogenous N-terminus tripeptide, Glycine-Proline-Glutamate (GPE), has been shown to be neuroprotective in animal models of brain injury.

   

8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDINYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE-D5

8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDINYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE-D5

C19H14ClD5N2 (315.15505429)


   

3-Fluoro-4-propyl-[1,1:4,1-terphenyl]-4-carbonitrile

3-Fluoro-4-propyl-[1,1:4,1-terphenyl]-4-carbonitrile

C22H18FN (315.14232)


   

3-METHOXY-4-[3-(1-PYRROLIDINYL)PROPOXY]-BENZOIC ACID HYDROCHLORIDE

3-METHOXY-4-[3-(1-PYRROLIDINYL)PROPOXY]-BENZOIC ACID HYDROCHLORIDE

C15H22ClNO4 (315.1237282)


   

2-(3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)propyl)isoindoline-1,3-dione

2-(3-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)propyl)isoindoline-1,3-dione

C17H22BNO4 (315.16418020000003)


   

5-Amino-1-Boc-3,4,5,6-tetrahydro-2H-[2,4]bipyridinyl hydrochloride

5-Amino-1-Boc-3,4,5,6-tetrahydro-2H-[2,4]bipyridinyl hydrochloride

C15H26ClN3O2 (315.1713446)


   

(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine

(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine

C16H15F2N5 (315.1295454)


   

Tert-Butyl 5-Methyl-3-Oxo-2,3-Dihydrospiro[Indene-1,4-Piperidine]-1-Carboxylate

Tert-Butyl 5-Methyl-3-Oxo-2,3-Dihydrospiro[Indene-1,4-Piperidine]-1-Carboxylate

C19H25NO3 (315.18343400000003)


   

Ramosetron Hydrochloride

Ramosetron Hydrochloride

C17H18ClN3O (315.1138328)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Ramosetron Hydrochloride(YM060 Hydrochloride) is a serotonin 5-HT3 receptor antagonist for the treatment of nausea and vomiting. Target: 5-HT3 Receptor Ramosetron hydrochloride selectively blocks serotonin receptors (5-HT3). Serotonin plays a vital role in vomiting, serotonin-induced bradycardic reflex and peristalsis. The pharmacological action of Ramosetron hydrochloride is sustained and potent.

   

1-(1-Ethoxycarbonyl-4-piperidinyl)-4-phenyl-4-imidazolin-2-one

1-(1-Ethoxycarbonyl-4-piperidinyl)-4-phenyl-4-imidazolin-2-one

C17H21N3O3 (315.1582836)


   

TERT-BUTYL 4-OXO-3,4-DIHYDRO-2H-SPIRO[NAPHTHALENE-1,4-PIPERIDINE]-1-CARBOXYLATE

TERT-BUTYL 4-OXO-3,4-DIHYDRO-2H-SPIRO[NAPHTHALENE-1,4-PIPERIDINE]-1-CARBOXYLATE

C19H25NO3 (315.18343400000003)


   

3-CHLORO-4-MORPHOLINOMETHYL BENZOPHENONE

3-CHLORO-4-MORPHOLINOMETHYL BENZOPHENONE

C18H18ClNO2 (315.1025998)


   

benzyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate

benzyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate

C18H21NO4 (315.1470506)


   

MPC 6827 hydrochloride

Verubulin hydrochloride

C17H18ClN3O (315.1138328)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   
   

4H-Cyclopenta[a][1,3]dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepin-1-ol, 1,5,6,8,9,14b-hexahydro-2-methoxy-

4H-Cyclopenta[a][1,3]dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepin-1-ol, 1,5,6,8,9,14b-hexahydro-2-methoxy-

C18H21NO4 (315.1470506)


   

N-(5-Fluoro-2-piperidin-1-ylphenyl)pyridine-4-carbothioamide

N-(5-Fluoro-2-piperidin-1-ylphenyl)pyridine-4-carbothioamide

C17H18FN3S (315.12054000000006)


   
   

N-(7-phenyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)benzamide

N-(7-phenyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)benzamide

C18H13N5O (315.1120048)


   

1-(4-Methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone

1-(4-Methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone

C17H21N3OS (315.14052560000005)


   

Talibegron

Talibegron

C18H21NO4 (315.1470506)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

Pyridoxal 4-methoxybenzoyl hydrazone

Pyridoxal 4-methoxybenzoyl hydrazone

C16H17N3O4 (315.1219002)


   

3H-Pyrazolo[3,4-b]pyridin-3-one, 2,7-dihydro-4,6-dimethyl-2,7-diphenyl-

3H-Pyrazolo[3,4-b]pyridin-3-one, 2,7-dihydro-4,6-dimethyl-2,7-diphenyl-

C20H17N3O (315.1371552)


   

1-[Oxo-(2-oxo-1-benzopyran-3-yl)methyl]-4-piperidinecarboxylic acid methyl ester

1-[Oxo-(2-oxo-1-benzopyran-3-yl)methyl]-4-piperidinecarboxylic acid methyl ester

C17H17NO5 (315.1106672)


   

N-[(4-chlorophenyl)methyl]-6-(3,5-dimethyl-1-pyrazolyl)-1,2,4,5-tetrazin-3-amine

N-[(4-chlorophenyl)methyl]-6-(3,5-dimethyl-1-pyrazolyl)-1,2,4,5-tetrazin-3-amine

C14H14ClN7 (315.0999154)


   

L-Leucine, L-seryl-L-prolyl-

L-Leucine, L-seryl-L-prolyl-

C14H25N3O5 (315.179412)


   

4,4-[(4-Iminocyclohexa-2,5-dien-1-ylidene)methylene]bis(2-methylaniline)

4,4-[(4-Iminocyclohexa-2,5-dien-1-ylidene)methylene]bis(2-methylaniline)

C21H21N3 (315.17353860000003)


   

N-trans-caffeoyloctopamine

N-trans-caffeoyloctopamine

C17H17NO5 (315.1106672)


   

Percodan

Percodan

C18H21NO4 (315.1470506)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

2-Butoxy-N-[2-(dimethylamino)ethyl]quinoline-4-carboxamide

2-Butoxy-N-[2-(dimethylamino)ethyl]quinoline-4-carboxamide

C18H25N3O2 (315.194667)


   

(1R*,3R*,3'S*)-1,2,3,4-Tetrahydro-1-(2-thio-3-pyrrolidinyl)-beta-carboline-3-carboxylic acid

1-(5-Sulphanyl-3,4-dihydro-2H-pyrrol-4-yl)-1H,2H,3H,4H,9H-pyrido[3,4-b]indole-3-carboxylic acid

C16H17N3O2S (315.1041422)


(1R*,3S*,3R*)-1,2,3,4-Tetrahydro-1-(2-thio-3-pyrrolidinyl)-beta-carboline-3-carboxylic acid is found in root vegetables. (1R*,3S*,3R*)-1,2,3,4-Tetrahydro-1-(2-thio-3-pyrrolidinyl)-beta-carboline-3-carboxylic acid is an alkaloid from fermented radish root Alkaloid from fermented radish roots. (1R*,3S*,3R*)-1,2,3,4-Tetrahydro-1-(2-thio-3-pyrrolidinyl)-beta-carboline-3-carboxylic acid is found in root vegetables.

   

(3R,9R,10R)-9-hydroxy-4-methyl-11,16,18-trioxa-4-azapentacyclo[11.7.0.02,10.03,7.015,19]icosa-1(20),7,13,15(19)-tetraen-12-one

(3R,9R,10R)-9-hydroxy-4-methyl-11,16,18-trioxa-4-azapentacyclo[11.7.0.02,10.03,7.015,19]icosa-1(20),7,13,15(19)-tetraen-12-one

C17H17NO5 (315.1106672)


   
   

C19-gibberellin skeleton

C19-gibberellin skeleton

C19H23O4- (315.1596258)


   
   
   

15-deoxy-Delta(12,14)-prostaglandin J2(1-)

15-deoxy-Delta(12,14)-prostaglandin J2(1-)

C20H27O3- (315.19600920000005)


A prostaglandin carboxylic acid anion that is the conjugate base of 15-deoxy-Delta(12,14)-prostaglandin J2. obtained by deprotonation of the carboxy group; major species at pH 7.3. D007155 - Immunologic Factors

   
   

(2S)-2-[[(2S)-2-aminopentanoyl]amino]-3-[[(E)-4-methoxy-4-oxobut-2-enoyl]amino]propanoic acid

(2S)-2-[[(2S)-2-aminopentanoyl]amino]-3-[[(E)-4-methoxy-4-oxobut-2-enoyl]amino]propanoic acid

C13H21N3O6 (315.1430286)


   

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Val-OH

3-[[(E)-4-Methoxy-4-oxo-2-butenoyl]amino]-L-Ala-L-Val-OH

C13H21N3O6 (315.1430286)


   

(+)-Norprotosinomenine

(+)-Norprotosinomenine

C18H21NO4 (315.1470506)


   

(1R)-1-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol

(1R)-1-[(4-hydroxy-3-methoxyphenyl)methyl]-6-methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol

C18H21NO4 (315.1470506)


   
   
   

Oct-4-enedioylcarnitine

Oct-4-enedioylcarnitine

C15H25NO6 (315.168179)


   

Oct-5-enedioylcarnitine

Oct-5-enedioylcarnitine

C15H25NO6 (315.168179)


   

(6Z)-Oct-6-enedioylcarnitine

(6Z)-Oct-6-enedioylcarnitine

C15H25NO6 (315.168179)


   

(2E)-Oct-2-enedioylcarnitine

(2E)-Oct-2-enedioylcarnitine

C15H25NO6 (315.168179)


   

(4aR,4bR,7R,9aR,10S,10aR)-1-methyl-8-methylene-13-oxododecahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylate

(4aR,4bR,7R,9aR,10S,10aR)-1-methyl-8-methylene-13-oxododecahydro-4a,1-(epoxymethano)-7,9a-methanobenzo[a]azulene-10-carboxylate

C19H23O4- (315.1596258)


   

Aculene A

Aculene A

C19H25NO3 (315.18343400000003)


A carboxylic ester resulting from the formal condensation of the hydroxy group of aculene C with the carboxylic acid group of L-proline. It is a sesquiterpenoid isolated from the fungus Aspergillus aculeatus.

   

Pyroglutamyltryptophan

Pyroglutamyltryptophan

C16H17N3O4 (315.1219002)


   

N-(2-ethoxyphenyl)-2-(4-methoxyphenoxy)propanamide

N-(2-ethoxyphenyl)-2-(4-methoxyphenoxy)propanamide

C18H21NO4 (315.1470506)


   

[4-[(2-Fluorophenyl)methoxy]phenyl]-(1-pyrrolidinyl)methanethione

[4-[(2-Fluorophenyl)methoxy]phenyl]-(1-pyrrolidinyl)methanethione

C18H18FNOS (315.10930700000006)


   

8-Chloro-5-isobutyl-1,2,3,4-tetrahydro-7-oxa-6,9,11-triaza-benzo[c]fluorene

8-Chloro-5-isobutyl-1,2,3,4-tetrahydro-7-oxa-6,9,11-triaza-benzo[c]fluorene

C17H18ClN3O (315.1138328)


   

N1-neopentyl-2-[1-(3,5-difluoro-2-hydroxyphenyl)ethylidene]hydrazine-1-carbothioamide

N1-neopentyl-2-[1-(3,5-difluoro-2-hydroxyphenyl)ethylidene]hydrazine-1-carbothioamide

C14H19F2N3OS (315.12168280000003)


   

2-oxo-1,4-dihydroquinazoline-3-carboxylic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

2-oxo-1,4-dihydroquinazoline-3-carboxylic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester

C17H21N3O3 (315.1582836)


   

N,N,2-trimethyl-1-phenyl-5-benzimidazolesulfonamide

N,N,2-trimethyl-1-phenyl-5-benzimidazolesulfonamide

C16H17N3O2S (315.1041422)


   

N-(3,7-dimethyl-2,6-octadienylidene)-2-nitrobenzohydrazide

N-(3,7-dimethyl-2,6-octadienylidene)-2-nitrobenzohydrazide

C17H21N3O3 (315.1582836)


   

6-(3-furanyl)-N-[(3-methylphenyl)methyl]-4-quinazolinamine

6-(3-furanyl)-N-[(3-methylphenyl)methyl]-4-quinazolinamine

C20H17N3O (315.1371552)


   

(12S)-4,5-Dimethoxy-12-methyl-13-oxa-10-azatetracyclo[8.7.0.02,7.011,15]heptadeca-2,4,6,11(15)-tetraen-14-one

(12S)-4,5-Dimethoxy-12-methyl-13-oxa-10-azatetracyclo[8.7.0.02,7.011,15]heptadeca-2,4,6,11(15)-tetraen-14-one

C18H21NO4 (315.1470506)


   
   

Pyranonigrin E

Pyranonigrin E

C18H21NO4 (315.1470506)


A member of the class of pyranopyrroles with formula C18H21NO4, originally isolated from Aspergillus niger.

   
   

N-benzyl-2,2-diphenylpropanamide

N-benzyl-2,2-diphenylpropanamide

C22H21NO (315.1623056)


   
   

Val-FMDP

Val-FMDP

C13H21N3O6 (315.1430286)


A dipeptide composed of 3-{[(2E)-4-methoxy-4-oxobut-2-enoyl]amino}alanine and L-valine joined by peptide linkages.

   

6-Amino-2-methyl-8-phenyl-1,6,8,8a-tetrahydroisoquinoline-5,7,7-tricarbonitrile

6-Amino-2-methyl-8-phenyl-1,6,8,8a-tetrahydroisoquinoline-5,7,7-tricarbonitrile

C19H17N5 (315.1483882)


   

4-Methyl-6-[2-(4-methyl-1-piperidinyl)-2-oxoethoxy]-1-benzopyran-2-one

4-Methyl-6-[2-(4-methyl-1-piperidinyl)-2-oxoethoxy]-1-benzopyran-2-one

C18H21NO4 (315.1470506)


   

2-(2,3,4-Trimethoxyphenyl)-2,3-dihydro-1,3-benzoxazin-4-one

2-(2,3,4-Trimethoxyphenyl)-2,3-dihydro-1,3-benzoxazin-4-one

C17H17NO5 (315.1106672)


   

1,3-Dimethyl-5-[1-(1-phenylethylamino)propylidene]-1,3-diazinane-2,4,6-trione

1,3-Dimethyl-5-[1-(1-phenylethylamino)propylidene]-1,3-diazinane-2,4,6-trione

C17H21N3O3 (315.1582836)


   

N-(4-fluorophenyl)-6-methyl-1-propyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxamide

N-(4-fluorophenyl)-6-methyl-1-propyl-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxamide

C18H22FN3O (315.1746814)


   

2-Ethoxy-3-pyridinecarboxylic acid (4-methoxycarbonylphenyl)methyl ester

2-Ethoxy-3-pyridinecarboxylic acid (4-methoxycarbonylphenyl)methyl ester

C17H17NO5 (315.1106672)


   

2-(cinnamoylamino)-N,N,4-trimethyl-1,3-thiazole-5-carboxamide

2-(cinnamoylamino)-N,N,4-trimethyl-1,3-thiazole-5-carboxamide

C16H17N3O2S (315.1041422)


   

1-(4-Methyl-3-nitrophenyl)-3-[(4-methylphenyl)methyl]thiourea

1-(4-Methyl-3-nitrophenyl)-3-[(4-methylphenyl)methyl]thiourea

C16H17N3O2S (315.1041422)


   

5-[(4-Methoxy-2-methylanilino)methylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

5-[(4-Methoxy-2-methylanilino)methylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

C16H17N3O4 (315.1219002)


   

N-(1-ethyl-5-benzimidazolyl)-4-methylbenzenesulfonamide

N-(1-ethyl-5-benzimidazolyl)-4-methylbenzenesulfonamide

C16H17N3O2S (315.1041422)


   

N-(3-methoxypropyl)-2-(4-oxochromeno[4,3-c]pyrazol-1-yl)acetamide

N-(3-methoxypropyl)-2-(4-oxochromeno[4,3-c]pyrazol-1-yl)acetamide

C16H17N3O4 (315.1219002)


   

(4Z)-5-methyl-4-[(1-methylindol-3-yl)methylidene]-2-phenylpyrazol-3-one

(4Z)-5-methyl-4-[(1-methylindol-3-yl)methylidene]-2-phenylpyrazol-3-one

C20H17N3O (315.1371552)


   

5,6-Dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolamine

5,6-Dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolamine

C16H17N3O2S (315.1041422)


   

N-(3,7-dimethyl-2,6-octadien-1-ylidene)-4-nitrobenzohydrazide

N-(3,7-dimethyl-2,6-octadien-1-ylidene)-4-nitrobenzohydrazide

C17H21N3O3 (315.1582836)


   

N-cycloheptyl-3-(5,7-dioxo-6-pyrrolo[3,4-b]pyridinyl)propanamide

N-cycloheptyl-3-(5,7-dioxo-6-pyrrolo[3,4-b]pyridinyl)propanamide

C17H21N3O3 (315.1582836)


   

(1R,5S)-6-[[5-(2-fluoro-4-methoxyphenyl)-1H-pyrazol-4-yl]methyl]-6-azabicyclo[3.2.1]octane

(1R,5S)-6-[[5-(2-fluoro-4-methoxyphenyl)-1H-pyrazol-4-yl]methyl]-6-azabicyclo[3.2.1]octane

C18H22FN3O (315.1746814)


   
   

(5-Methyl-1,2-oxazol-3-yl)-[4-(5-propylpyrimidin-2-yl)piperazin-1-yl]methanone

(5-Methyl-1,2-oxazol-3-yl)-[4-(5-propylpyrimidin-2-yl)piperazin-1-yl]methanone

C16H21N5O2 (315.1695166)


   

[(E)-1-[5-(3-methylbutoxymethyl)-2-oxooxolan-3-yl]propan-2-ylideneamino]thiourea

[(E)-1-[5-(3-methylbutoxymethyl)-2-oxooxolan-3-yl]propan-2-ylideneamino]thiourea

C14H25N3O3S (315.161654)


   

[2-(furan-2-ylmethylamino)-2-oxoethyl] (E)-3-(3-methoxyphenyl)prop-2-enoate

[2-(furan-2-ylmethylamino)-2-oxoethyl] (E)-3-(3-methoxyphenyl)prop-2-enoate

C17H17NO5 (315.1106672)


   

3-O-Acetyl-8-O-demethylmaritidine

3-O-Acetyl-8-O-demethylmaritidine

C18H21NO4 (315.1470506)


   
   
   
   
   
   
   
   

(1-Methyl-3-imidazo[1,2-a]pyridin-4-iumyl)-diphenylmethanol

(1-Methyl-3-imidazo[1,2-a]pyridin-4-iumyl)-diphenylmethanol

C21H19N2O+ (315.1497304)


   

N-[(3,4,5-trimethoxyphenyl)methylideneamino]pyridine-3-carboxamide

N-[(3,4,5-trimethoxyphenyl)methylideneamino]pyridine-3-carboxamide

C16H17N3O4 (315.1219002)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(2E)-7-carboxyhept-2-enoylcarnitine

(2E)-7-carboxyhept-2-enoylcarnitine

C15H25NO6 (315.168179)


An O-acylcarnitine having (2E)-7-carboxyhept-2-enoyl as the acyl substituent.

   
   
   
   

(2E)-10-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dec-2-enoate

(2E)-10-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]dec-2-enoate

C16H27O6- (315.1807542)


   

(2S)-2-amino-N-[(E)-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methylidene]-3-phenylpropanehydrazide (non-preferred name)

(2S)-2-amino-N-[(E)-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methylidene]-3-phenylpropanehydrazide (non-preferred name)

C15H17N5O3 (315.1331332)


   

N-[(E)-(2,5-Dimethoxyphenyl)methylideneamino]-1-methyl-6-oxopyridine-3-carboxamide

N-[(E)-(2,5-Dimethoxyphenyl)methylideneamino]-1-methyl-6-oxopyridine-3-carboxamide

C16H17N3O4 (315.1219002)


   

6-[4-(2-chlorophenyl)piperazin-1-yl]-7H-purin-1-ium

6-[4-(2-chlorophenyl)piperazin-1-yl]-7H-purin-1-ium

C15H16ClN6+ (315.1124906)


   

(E,9R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxydec-2-enoate

(E,9R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxydec-2-enoate

C16H27O6- (315.1807542)


   

N-hydroxy-1,3-dimethyl-3-nitrospiro[cyclohepta[d]imidazol-3-ium-2,4-cyclohexa-2,5-diene]-1-imine oxide

N-hydroxy-1,3-dimethyl-3-nitrospiro[cyclohepta[d]imidazol-3-ium-2,4-cyclohexa-2,5-diene]-1-imine oxide

C15H15N4O4+ (315.109325)


   

(1S)-1-(3-Hydroxy-4-methoxybenzyl)-2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline

(1S)-1-(3-Hydroxy-4-methoxybenzyl)-2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline

C18H21NO4 (315.1470506)


   

Saxagliptin (BMS-477118,Onglyza)

Saxagliptin (BMS-477118,Onglyza)

C18H25N3O2 (315.194667)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D054795 - Incretins D007004 - Hypoglycemic Agents > D054873 - Dipeptidyl-Peptidase IV Inhibitors D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   

2-Ethoxy-N-(2-(diethylamino)ethyl)-4-quinolinecarboxamide

2-Ethoxy-N-(2-(diethylamino)ethyl)-4-quinolinecarboxamide

C18H25N3O2 (315.194667)


   

4-[3-Amino-6-(4-cyanophenyl)pyrazin-2-yl]benzamide

4-[3-Amino-6-(4-cyanophenyl)pyrazin-2-yl]benzamide

C18H13N5O (315.1120048)


   

[(2R)-2-(4-chlorophenyl)cyclopropyl]-[4-(2-hydroxyethylamino)phenyl]methanone

[(2R)-2-(4-chlorophenyl)cyclopropyl]-[4-(2-hydroxyethylamino)phenyl]methanone

C18H18ClNO2 (315.1025998)


   

2-Butoxy-N-(2-(ethylamino)ethyl)-4-quinolinecarboxamide

2-Butoxy-N-(2-(ethylamino)ethyl)-4-quinolinecarboxamide

C18H25N3O2 (315.194667)


   

N-methylcoclaurine N-oxide

N-methylcoclaurine N-oxide

C18H21NO4 (315.1470506)


   

N-Acetyl-alanyl-valyl-alanine methyl ester

N-Acetyl-alanyl-valyl-alanine methyl ester

C14H25N3O5 (315.179412)


   

N-Acetyl-alanyl-leucyl-glycine methylester

N-Acetyl-alanyl-leucyl-glycine methylester

C14H25N3O5 (315.179412)


   

N-Acetyl-glycyl-leucyl-alanine methylester

N-Acetyl-glycyl-leucyl-alanine methylester

C14H25N3O5 (315.179412)


   

2-Ethoxycarbonyl-3-ethyl-4-methyl-5-benzyloxycarbonyl-pyrrole

2-Ethoxycarbonyl-3-ethyl-4-methyl-5-benzyloxycarbonyl-pyrrole

C18H21NO4 (315.1470506)


   

2,4-Diisopropyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

2,4-Diisopropyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione

C17H21N3O3 (315.1582836)


   
   
   

Neosaxitoxin

Neosaxitoxin

C10H17N7O5 (315.1291112)


A pyrrolopurine that is saxitoxin carrying a hydroxy substituent on the nitrogen atom at position 5. It is a sodium channel blocker that is undergoing clinical trials as a prolonged-duration local anesthetic.

   

(±)-Rotigotine

1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-

C19H25NOS (315.165676)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   
   

(1R*,3R*,3S*)-1,2,3,4-Tetrahydro-1-(2-thio-3-pyrrolidinyl)-beta-carboline-3-carboxylic acid

(1R*,3R*,3S*)-1,2,3,4-Tetrahydro-1-(2-thio-3-pyrrolidinyl)-beta-carboline-3-carboxylic acid

C16H17N3O2S (315.1041422)


   
   

3,7-Diamino-2,8-dimethyl-5-phenylphenazin-5-ium

3,7-Diamino-2,8-dimethyl-5-phenylphenazin-5-ium

C20H19N4+ (315.1609634)


   

oscr#15(1-)

oscr#15(1-)

C16H27O6 (315.1807542)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#15, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ascr#15(1-)

ascr#15(1-)

C16H27O6 (315.1807542)


Conjugate base of ascr#15

   

O-octenedioylcarnitine

O-octenedioylcarnitine

C15H25NO6 (315.168179)


An O-acylcarnitine obtained by formal condensation of one of the carboxy groups of any octenedioic acid with the hydroxy group of carnitine.

   

gibberellin A9(1-)

gibberellin A9(1-)

C19H23O4 (315.1596258)


A gibberellin carboxylic acid anion that is the conjugate base of gibberellin A9, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(R,S)-Norreticuline

(R,S)-Norreticuline

C18H21NO4 (315.1470506)


   
   
   
   

2'-O-MOE-5-Me-rC

2'-O-MOE-5-Me-rC

C13H21N3O6 (315.1430286)


2'-O-MOE-5-Me-rC is an active compound. 2'-O-MOE-5-Me-rC can be used for oligonucleotide synthesis[1].

   

A-804598

A-804598

C19H17N5 (315.1483882)


A-804598 is a CNS penetrant, competitive and selective P2X7 receptor antagonist with IC50s of 9 nM, 10 nM and 11 nM for mouse, rat and human P2X7 receptors, respectively[1].

   

APX-115

APX-115

C17H18ClN3O (315.1138328)


APX-115 (Ewha-18278) is a potent, orally active pan NADPH oxidase (Nox) inhibitor with Ki values of 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2 and Nox4, respectively. APX-115 effectively prevents kidney injury[1].

   

NG-497

NG-497

C18H21NO4 (315.1470506)


NG-497 is a selective human adipose triglyceride lipase (ATGL) inhibitor that targets the enzymatically active patatin-like domain of human ATGL. NG-497 has potential value for tumor research[1].